Ideagen plc (IDEA) is a leading software-application business based in the UK. Ideagen is listed on the London Stock Exchange (LSE) and employs 527 staff. All prices are listed in pence sterling.
|52-week range||135.8671p - 314p|
|50-day moving average||258.5882p|
|200-day moving average||215.2571p|
|Wall St. target price||180p|
|Dividend yield||0p (0.11%)|
|Earnings per share (TTM)||1p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Ideagen stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ideagen's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ideagen's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 180x. In other words, Ideagen shares trade at around 180x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Ideagen's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £9.6 million.
The EBITDA is a measure of a Ideagen's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||£56.6 million|
|Operating margin TTM||6.87%|
|Gross profit TTM||£51.4 million|
|Return on assets TTM||1.82%|
|Return on equity TTM||-0.26%|
|Market capitalisation||£711 million|
TTM: trailing 12 months
We're not expecting Ideagen to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, Ideagen's shares have ranged in value from as little as 135.8671p up to 314p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Ideagen's is 0.9694. This would suggest that Ideagen's shares are less volatile than average (for this exchange).
Ideagen plc develops and sells information management software in the United Kingdom, rest of Europe, North America, the Middle East, and internationally. Its governance, risk, and compliance (GRC) solutions include Q-Pulse QMS, a quality management software; Q-Pulse PM, a product management software; Q-Pulse Law, an EHS legal compliance software; Q-Pulse WorkRite, a health and safety management system; Pentana Audit, an audit automation software; Pentana Disclose, a financial disclosure checklist software; Pentana Compliance, an accountability and competency compliance software; and Pentana Risk, a cloud-based performance and risk management software. The company's GRC solutions also comprise Coruson, an enterprise cloud-based safety management software; PleaseReview, a document review, co-authoring, and redaction software; and Ideagen Academy, a cloud-based E-learning solution. It serves aerospace and defense, accounting, finance and banking, construction, aviation, energy, food and drink, healthcare, life science, and manufacturing industries. The company was formerly known as Datum International Plc and changed its name to Ideagen plc in July 2011. Ideagen plc was founded in 1993 and is headquartered in Ruddington, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.